Pharmacokinetic study of Benralizumab in Healthy Chinese Subjects

Trial Identifier:	D3250C00034
Sponsor:	AstraZeneca
NCTID::	NCT03928262
Start Date:	April 2019
Primary Completion Date:	August 2019
Study Completion Date:	August 2019
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	Traditional Chinese Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Hong Kong	Hong Kong, Hong Kong, NA

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.